Pharmacokinetics, mass balance, and metabolism of [14C]PLB1004, a selective and irreversible EGFR-TKI in humans.
Liu D, Li Q, Yan S, Zhang X, Li W, Wang F, Gao L, Geng F, Zhou H, Ye P, Zhao F, Xue W, Zhang P, Diao X, Zhao W.
Liu D, et al. Among authors: yan s.
Cancer Chemother Pharmacol. 2025 Jan 7;95(1):19. doi: 10.1007/s00280-024-04744-7.
Cancer Chemother Pharmacol. 2025.
PMID: 39776242